Cargando…
Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines
Immunotherapy for treating IgE-mediated allergies requires high doses of the corresponding allergen. This may result in undesired side effects and, to avoid them, hypoallergenic allergens (allergoids) polymerized with glutaraldehyde are commonly used. Targeting allergoids to dendritic cells to enhan...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722057/ https://www.ncbi.nlm.nih.gov/pubmed/26603537 http://dx.doi.org/10.1007/s10719-015-9640-4 |
_version_ | 1782411311504687104 |
---|---|
author | Manzano, Ana I. Javier Cañada, F. Cases, Bárbara Sirvent, Sofia Soria, Irene Palomares, Oscar Fernández-Caldas, Enrique Casanovas, Miguel Jiménez-Barbero, Jesús Subiza, José L. |
author_facet | Manzano, Ana I. Javier Cañada, F. Cases, Bárbara Sirvent, Sofia Soria, Irene Palomares, Oscar Fernández-Caldas, Enrique Casanovas, Miguel Jiménez-Barbero, Jesús Subiza, José L. |
author_sort | Manzano, Ana I. |
collection | PubMed |
description | Immunotherapy for treating IgE-mediated allergies requires high doses of the corresponding allergen. This may result in undesired side effects and, to avoid them, hypoallergenic allergens (allergoids) polymerized with glutaraldehyde are commonly used. Targeting allergoids to dendritic cells to enhance cell uptake may result in a more effective immunotherapy. Allergoids coupled to yeast mannan, as source of polymannoses, would be suitable for this purpose, since mannose-binding receptors are expressed on these cells. Conventional conjugation procedures of mannan to proteins use oxidized mannan to release reactive aldehydes able to bind to free amino groups in the protein; yet, allergoids lack these latter because their previous treatment with glutaraldehyde. The aim of this study was to obtain allergoids conjugated to mannan by an alternative approach based on just glutaraldehyde treatment, taking advantage of the mannoprotein bound to the polymannose backbone. Allergoid-mannan glycoconjugates were produced in a single step by treating with glutaraldehyde a defined mixture of allergens derived from Phleum pratense grass pollen and native mannan (non-oxidized) from Saccharomyces cerevisae. Analytical and structural studies, including 2D-DOSY and (1)H-(13)C HSQC nuclear magnetic resonance spectra, demonstrated the feasibility of such an approach. The glycoconjugates obtained were polymers of high molecular weight showing a higher stability than the native allergen or the conventional allergoid without mannan. The allergoid-mannan glycoconjugates were hypoallergenic as detected by the IgE reactivity with sera from grass allergic patients, even with lower reactivity than conventional allergoid without mannan. Thus, stable hypoallergenic allergoids conjugated to mannan suitable for using in immunotherapy can be achieved using glutaraldehyde. In contrast to mannan oxidation, the glutaraldehyde approach allows to preserve mannoses with their native geometry, which may be functionally important for its receptor-mediated recognition. |
format | Online Article Text |
id | pubmed-4722057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-47220572016-02-01 Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines Manzano, Ana I. Javier Cañada, F. Cases, Bárbara Sirvent, Sofia Soria, Irene Palomares, Oscar Fernández-Caldas, Enrique Casanovas, Miguel Jiménez-Barbero, Jesús Subiza, José L. Glycoconj J Original Article Immunotherapy for treating IgE-mediated allergies requires high doses of the corresponding allergen. This may result in undesired side effects and, to avoid them, hypoallergenic allergens (allergoids) polymerized with glutaraldehyde are commonly used. Targeting allergoids to dendritic cells to enhance cell uptake may result in a more effective immunotherapy. Allergoids coupled to yeast mannan, as source of polymannoses, would be suitable for this purpose, since mannose-binding receptors are expressed on these cells. Conventional conjugation procedures of mannan to proteins use oxidized mannan to release reactive aldehydes able to bind to free amino groups in the protein; yet, allergoids lack these latter because their previous treatment with glutaraldehyde. The aim of this study was to obtain allergoids conjugated to mannan by an alternative approach based on just glutaraldehyde treatment, taking advantage of the mannoprotein bound to the polymannose backbone. Allergoid-mannan glycoconjugates were produced in a single step by treating with glutaraldehyde a defined mixture of allergens derived from Phleum pratense grass pollen and native mannan (non-oxidized) from Saccharomyces cerevisae. Analytical and structural studies, including 2D-DOSY and (1)H-(13)C HSQC nuclear magnetic resonance spectra, demonstrated the feasibility of such an approach. The glycoconjugates obtained were polymers of high molecular weight showing a higher stability than the native allergen or the conventional allergoid without mannan. The allergoid-mannan glycoconjugates were hypoallergenic as detected by the IgE reactivity with sera from grass allergic patients, even with lower reactivity than conventional allergoid without mannan. Thus, stable hypoallergenic allergoids conjugated to mannan suitable for using in immunotherapy can be achieved using glutaraldehyde. In contrast to mannan oxidation, the glutaraldehyde approach allows to preserve mannoses with their native geometry, which may be functionally important for its receptor-mediated recognition. Springer US 2015-11-25 2016 /pmc/articles/PMC4722057/ /pubmed/26603537 http://dx.doi.org/10.1007/s10719-015-9640-4 Text en © The Author(s) 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Manzano, Ana I. Javier Cañada, F. Cases, Bárbara Sirvent, Sofia Soria, Irene Palomares, Oscar Fernández-Caldas, Enrique Casanovas, Miguel Jiménez-Barbero, Jesús Subiza, José L. Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines |
title | Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines |
title_full | Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines |
title_fullStr | Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines |
title_full_unstemmed | Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines |
title_short | Structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines |
title_sort | structural studies of novel glycoconjugates from polymerized allergens (allergoids) and mannans as allergy vaccines |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722057/ https://www.ncbi.nlm.nih.gov/pubmed/26603537 http://dx.doi.org/10.1007/s10719-015-9640-4 |
work_keys_str_mv | AT manzanoanai structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines AT javiercanadaf structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines AT casesbarbara structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines AT sirventsofia structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines AT soriairene structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines AT palomaresoscar structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines AT fernandezcaldasenrique structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines AT casanovasmiguel structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines AT jimenezbarberojesus structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines AT subizajosel structuralstudiesofnovelglycoconjugatesfrompolymerizedallergensallergoidsandmannansasallergyvaccines |